Cargando…
Metabolic Adaptation to Chronic Inhibition of Mitochondrial Protein Synthesis in Acute Myeloid Leukemia Cells
Recently, we demonstrated that the anti-bacterial agent tigecycline preferentially induces death in leukemia cells through the inhibition of mitochondrial protein synthesis. Here, we sought to understand mechanisms of resistance to tigecycline by establishing a leukemia cell line resistant to the dr...
Autores principales: | Jhas, Bozhena, Sriskanthadevan, Shrivani, Skrtic, Marko, Sukhai, Mahadeo A., Voisin, Veronique, Jitkova, Yulia, Gronda, Marcela, Hurren, Rose, Laister, Rob C., Bader, Gary D., Minden, Mark D., Schimmer, Aaron D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3592803/ https://www.ncbi.nlm.nih.gov/pubmed/23520503 http://dx.doi.org/10.1371/journal.pone.0058367 |
Ejemplares similares
-
A Novel Formulation of Tigecycline Has Enhanced Stability and Sustained Antibacterial and Antileukemic Activity
por: Jitkova, Yulia, et al.
Publicado: (2014) -
A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia
por: Reed, Gregory A., et al.
Publicado: (2016) -
A novel isoflavone, ME-344, targets the cytoskeleton in acute myeloid leukemia
por: Jeyaraju, Danny V., et al.
Publicado: (2016) -
The thymidine dideoxynucleoside analog, alovudine, inhibits the mitochondrial DNA polymerase γ, impairs oxidative phosphorylation and promotes monocytic differentiation in acute myeloid leukemia
por: Yehudai, Dana, et al.
Publicado: (2019) -
Suppression of Cancer Progression by MGAT1 shRNA Knockdown
por: Beheshti Zavareh, Reza, et al.
Publicado: (2012)